Drug Approval | October 02, 2024
SMS Pharma receives EDQM certification to supply Ibuprofen in Europe
The inspection conducted by EDQM at its Visakhapatnam facility
The inspection conducted by EDQM at its Visakhapatnam facility
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
Laurus Labs receives EIR from USFDA for API facilities
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Lupin enters into BTA with Lupin Manufacturing Solutions
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Subscribe To Our Newsletter & Stay Updated
